135 related articles for article (PubMed ID: 6252377)
1. The ether-catalyzed dissociation rate of estradiol-receptor complex distinguishes between hormone-sensitive and resistant rat mammary tumors.
Hollander VP; Khan S
J Steroid Biochem; 1980 Jan; 12():131-4. PubMed ID: 6252377
[No Abstract] [Full Text] [Related]
2. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
[TBL] [Abstract][Full Text] [Related]
3. Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours.
Hawkins RA; Hill A; Freedman B; Killen E; Buchan P; Miller WR; Forrest AP
Eur J Cancer (1965); 1977 Mar; 13(3):223-8. PubMed ID: 405220
[No Abstract] [Full Text] [Related]
4. Prolactin and estrogen binding sites in the mammary gland of the lactating and non-lactating rat.
Bohnet HG; Gómez F; Friesen HG
Endocrinology; 1977 Oct; 101(4):1111-21. PubMed ID: 198196
[No Abstract] [Full Text] [Related]
5. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
Diamond EJ; Giladi M; Khan S; Hollander VP
Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
[TBL] [Abstract][Full Text] [Related]
6. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
Turcot-Lemay L; Kelly PA
Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
[No Abstract] [Full Text] [Related]
7. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Arafah BM; Manni A; Pearson OH
Endocrinology; 1980 Nov; 107(5):1364-9. PubMed ID: 6253265
[No Abstract] [Full Text] [Related]
8. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
Powell BL; Diamond EJ; Koprak S; Hollander VP
Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
[TBL] [Abstract][Full Text] [Related]
9. Mammary cancer: selective action of the estrogen receptor complex.
Ip M; Milholland RJ; Rosen F; Kim U
Science; 1979 Jan; 203(4378):361-3. PubMed ID: 760195
[TBL] [Abstract][Full Text] [Related]
10. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
Manni A; Trujillo JE; Pearson OH
Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
[TBL] [Abstract][Full Text] [Related]
11. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
Costlow ME; Buschow RA; Richert NJ; McGuire WL
Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
Edery M; Drosdowsky MA
Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
[TBL] [Abstract][Full Text] [Related]
13. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations in levels of cytosol and nuclear estrogen receptors in rat mammary tumors during the estrous cycle.
Shih A; Lee C
Endocrinology; 1978 Feb; 102(2):420-5. PubMed ID: 570481
[No Abstract] [Full Text] [Related]
15. Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat.
Asselin J; Labrie F
J Steroid Biochem; 1978 Nov; 9(11):1079-82. PubMed ID: 106188
[No Abstract] [Full Text] [Related]
16. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
17. Effects of plasma estrogen sulfates in mammary cancer cells.
Vignon F; Terqui M; Westley B; Derocq D; Rochefort H
Endocrinology; 1980 Apr; 106(4):1079-86. PubMed ID: 6244140
[No Abstract] [Full Text] [Related]
18. Heterogeneity of estrogen binding sites in mammary tumors.
Clark JH; Watson CS; Markaverich BM; Syne JS; Panko WB
Breast Cancer Res Treat; 1983; 3(1):61-5. PubMed ID: 6871482
[TBL] [Abstract][Full Text] [Related]
19. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
Abul-Hajj YJ
J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
[No Abstract] [Full Text] [Related]
20. Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors.
Kelly PA; Asselin J; Turcot-Lemay L; Labrie F; Raynaud JP
Eur J Cancer (1965); 1979 Oct; 15(10):1243-51. PubMed ID: 230056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
